3,4 "We are pleased to see the clinically meaningful weight loss in people treated with our oral GLP-1 therapy CT-996, which could eventually help patients address both chronic weight management and glycaemic control indications, said Levi Garraway, M.D., Ph.D., Roches Chief Medical Officer and Head of Global Product Development
Im very pleased."
Between the two, semaglutide and tirzepatide consistently lead the clinical data, and the right choice usually depends on BMI, metabolic history, and how the body responds to the starting dose
Antioxidants have anti-inflammatory properties and fight oxidative stress by targeting toxic molecules known as free radicals, which can be produced in the body or found in substances that harm the environment
At Viata Aesthetics and Wellness, we are committed to supporting you on your journey towards a healthier lifestyle